Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration
Objective Standard treatment of neovascular age-related macular degeneration (nAMD) is intravitreal injections (IVI) of antivascular endothelial growth factor (anti-VEGF) according to treat-and-extend (TnE). Observe-and-plan (OnP), a new regimen based on each individual’s relapse interval lead to fe...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-10-01
|
| Series: | BMJ Open Ophthalmology |
| Online Access: | https://bmjophth.bmj.com/content/7/1/e000930.full |
| _version_ | 1797777433861029888 |
|---|---|
| author | Dordi Austeng Tora Sund Morken Christina Knutsen Margrete Sætre Hanssen |
| author_facet | Dordi Austeng Tora Sund Morken Christina Knutsen Margrete Sætre Hanssen |
| author_sort | Dordi Austeng |
| collection | DOAJ |
| description | Objective Standard treatment of neovascular age-related macular degeneration (nAMD) is intravitreal injections (IVI) of antivascular endothelial growth factor (anti-VEGF) according to treat-and-extend (TnE). Observe-and-plan (OnP), a new regimen based on each individual’s relapse interval lead to fewer clinical visits and has so far shown to be safe in treatment-naïve patients. In this study, we explore patient satisfaction and safety in nAMD when switching from TnE to OnP.Methods and analysis 38 participants treated acording to TnE for ≥12 months were included and switched from TnE to OnP with their last stable interval. Main outcome was patient satisfaction (Leeds Satisfaction Questionnaire). Secondary outcomes were best-corrected visual acuity (BCVA), central retinal thickness (CRT) before and 12 months after switch and number of monitoring visits and injections of anti-VEGF 12 months prior to and following switch.Results Mean patient satisfaction was higher (3.7±0.5 SD) at 12 months after switch from TnE to OnP than before (3.6±0.5 SD, p=0.009, response rate 76%). BCVA and CRT were unchanged. Number of monitoring visits and injections were lower in the 12 months following than prior to switch (p<0.001).Conclusion A switch from TnE to OnP in a non-treatment-naïve population resulted in higher patient satisfaction, while maintaining stable BCVA. This indicates that OnP may be applicable in the large group of nAMD patients that have received IVI for several years. OnP may alleviate the treatment burden on both individual and society of frequent clinical visits while increasing patient satisfaction. |
| first_indexed | 2024-03-12T23:04:52Z |
| format | Article |
| id | doaj.art-9d610351dabc43a79b363e5c0de3b7a4 |
| institution | Directory Open Access Journal |
| issn | 2397-3269 |
| language | English |
| last_indexed | 2024-03-12T23:04:52Z |
| publishDate | 2022-10-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open Ophthalmology |
| spelling | doaj.art-9d610351dabc43a79b363e5c0de3b7a42023-07-19T04:30:06ZengBMJ Publishing GroupBMJ Open Ophthalmology2397-32692022-10-017110.1136/bmjophth-2021-000930Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degenerationDordi Austeng0Tora Sund Morken1Christina Knutsen2Margrete Sætre Hanssen3Department of Ophthalmology, St.Olav hospital, Trondheim University Hospital, Trondheim, NorwayDepartment of Ophthalmology, St.Olav hospital, Trondheim University Hospital, Trondheim, NorwayFaculty of Medicine and Health Sciences, NTNU, Trondheim, NorwayDepartment of Ophthalmology, St.Olav hospital, Trondheim University Hospital, Trondheim, NorwayObjective Standard treatment of neovascular age-related macular degeneration (nAMD) is intravitreal injections (IVI) of antivascular endothelial growth factor (anti-VEGF) according to treat-and-extend (TnE). Observe-and-plan (OnP), a new regimen based on each individual’s relapse interval lead to fewer clinical visits and has so far shown to be safe in treatment-naïve patients. In this study, we explore patient satisfaction and safety in nAMD when switching from TnE to OnP.Methods and analysis 38 participants treated acording to TnE for ≥12 months were included and switched from TnE to OnP with their last stable interval. Main outcome was patient satisfaction (Leeds Satisfaction Questionnaire). Secondary outcomes were best-corrected visual acuity (BCVA), central retinal thickness (CRT) before and 12 months after switch and number of monitoring visits and injections of anti-VEGF 12 months prior to and following switch.Results Mean patient satisfaction was higher (3.7±0.5 SD) at 12 months after switch from TnE to OnP than before (3.6±0.5 SD, p=0.009, response rate 76%). BCVA and CRT were unchanged. Number of monitoring visits and injections were lower in the 12 months following than prior to switch (p<0.001).Conclusion A switch from TnE to OnP in a non-treatment-naïve population resulted in higher patient satisfaction, while maintaining stable BCVA. This indicates that OnP may be applicable in the large group of nAMD patients that have received IVI for several years. OnP may alleviate the treatment burden on both individual and society of frequent clinical visits while increasing patient satisfaction.https://bmjophth.bmj.com/content/7/1/e000930.full |
| spellingShingle | Dordi Austeng Tora Sund Morken Christina Knutsen Margrete Sætre Hanssen Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration BMJ Open Ophthalmology |
| title | Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration |
| title_full | Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration |
| title_fullStr | Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration |
| title_full_unstemmed | Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration |
| title_short | Patient satisfaction following a switch from treat-and-extend to observe-and-plan regimen in age-related macular degeneration |
| title_sort | patient satisfaction following a switch from treat and extend to observe and plan regimen in age related macular degeneration |
| url | https://bmjophth.bmj.com/content/7/1/e000930.full |
| work_keys_str_mv | AT dordiausteng patientsatisfactionfollowingaswitchfromtreatandextendtoobserveandplanregimeninagerelatedmaculardegeneration AT torasundmorken patientsatisfactionfollowingaswitchfromtreatandextendtoobserveandplanregimeninagerelatedmaculardegeneration AT christinaknutsen patientsatisfactionfollowingaswitchfromtreatandextendtoobserveandplanregimeninagerelatedmaculardegeneration AT margretesætrehanssen patientsatisfactionfollowingaswitchfromtreatandextendtoobserveandplanregimeninagerelatedmaculardegeneration |